The cannabis industry has rapidly transitioned from an obscure counterculture movement to a legal industry that could exceed $27 billion by 2024, according to the MJBiz Daily. In addition to a growing number of states legalizing cannabis, the industry has evolved to provide a growing array of different products, including tinctures, topicals, edibles—and beverages.   

Let’s take a look at the rise of cannabis-infused beverages and how you can invest in Innoviom, Inc.—a pioneer in the space—with as little as $2,500 through the MAZAKALI platform to capitalize on these trends.

Cannabis-Infused Beverages

Cannabis beverages are projected to become a $2.8 billion market by 2025, according to Grand View Research, which represents a blistering 17.8% compound annual growth rate. While the industry is highly fragmented at the moment, Molson Coors projects that cannabis drinks will eventually represent one-third of all cannabis sales as the industry matures.

Click here to receive more information on investing in Innoviom

Several large companies have already begun to position themselves in the space:

• Heineken launched Hi-Fi Hops—a CBD and THC-infused beverage with zero calories.
• Molson Coors took a controlling stake in HEXO Inc., a Canadian licensed producer.
• Anheuser-Busch InBev invested $50 million in a joint venture with Tilray Inc.
• Constellation Brands acquired a 38% stake in Canopy Growth Corp. for $4 billion.

Many alcohol conglomerates believe that THC-infused beverages could compete with alcohol in the future and seek to position themselves to diversify risk. However, Millennials appear to be equally interested in CBD-infused functional beverages that incorporate natural substances, like adaptogens, probiotics and vitamins, to improve wellness. 

Innoviom Makes Big Progress

Innoviom was founded by executives from Coca-Cola, Pepsi, RedBull and other leading beverage brands to build on these CBD wellness trends and take them to scale. The company’s Wowie brand is a hemp-infused beverage that contains 20mg of hemp and a mix of adaptogens designed to promote relaxation.

In combination with Tranquini and its new NaturGeeks brands, the company has been consistently doubling its sales each month through Amazon.com and other online platforms. Management expects to be live in the UK on December 1 and rollout its products in the European Union in January of next year amid its international expansion.

Click here to receive more information on investing in Innoviom

With an established supply chain, manufacturing and distribution network already in place, the company is well on its way to expanding its presence throughout the United States. The company’s move to trademark the name in 120 countries and seek regulatory approval in 30+ countries suggests that further international expansion is also in the cards.

How to Invest in Innoviom

Innoviom has recently announced a $3 million capital raise in order to support its growth. While the company has already closed $1.2 million in funding for this round, interested investors still have an opportunity to participate in the remainder of the financing round over the coming weeks.

Accredited investors can participate in a direct private placement with a minimum investment of $30,000 or invest in MAZAKALI’s Special Investment Vehicle with a minimum investment of just $2,500. For more information, sign up for MAZAKALI’s platform and access the terms.

Click here to receive more information on investing in Innoviom

The Bottom Line

Cannabis beverages have already attracted tremendous interest in both the alcohol and wellness industries. With its unique combination of cannabinoid and non-cannabinoid relaxation beverages, Innoviom is well positioned to benefit from an increase in demand for CBD-infused functional beverages.

For more information, visit the company’s website or request more information today!

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.